tyramine and Depression studies

Depression: Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.

Research Excerpts

Excerpt	Relevance	Reference
"Corticosterone treatment altered all parameters in behavioral tests, leading to a depressive- and anxious-like behavior."	5.51	Reversal effect of Riparin IV in depression and anxiety caused by corticosterone chronic administration in mice. ( Barbosa Filho, JM; Capibaribe, VCC; Chaves, RC; da Silva, DMA; de Carvalho, AMR; de Sousa, FCF; Gutierrez, SJC; Lopes, IS; Macêdo, DS; Mallmann, ASV; Oliveira, ICM; Oliveira, NF; Valentim, JT; Vasconcelos, SMM, 2019)
" This study aimed to investigate the activity of RIP II in a corticosterone-induced depression mice model."	3.88	Riparin II ameliorates corticosterone-induced depressive-like behavior in mice: Role of antioxidant and neurotrophic mechanisms. ( Barbosa Filho, JM; Capibaribe, VCC; Chaves, RC; da Silva, DMA; de Araújo, MA; de Sousa, FCF; de Souza, AG; Gutierrez, SJC; Lopes, IS; Macêdo, DS; Oliveira, ICM; Valentim, JT, 2018)
" The trial's goal was to investigate the activity of Rip III in mice exposed to corticosterone-induced chronic depression model."	3.81	Subchronic administration of riparin III induces antidepressive-like effects and increases BDNF levels in the mouse hippocampus. ( Barbosa-Filho, JM; de França Fonteles, MM; de Sousa, FC; Gaspar, DM; Gutierrez, SJ; Oliveira, IC; Rodrigues, GC; Vasconcelos, AS; Vasconcelos, SM; Vidal, LT, 2015)
"Patients with reactive depression and those with endogenous depression reponded equally well to Org GB 94."	2.64	Clinical and pharmacological effects of treatment with a new antidepressant. ( Coppen, AJ; Ghose, K, 1976)
" Based on these findings, this study aimed to investigate the possible effects of Riparin IV (Rip IV) on cognitive impairment induced by chronic administration of corticosterone in mice."	1.56	The neuroprotective effect of Riparin IV on oxidative stress and neuroinflammation related to chronic stress-induced cognitive impairment. ( Barbosa Filho, JM; Barbosa, GR; Capibaribe, VCC; Chaves, RC; da Silva, DMA; de Carvalho, AMR; de Oliveira, NF; de Sousa, FCF; Fonteles, MMF; Gutierrez, SJC; Lopes, IS; Mallmann, ASV; Valentim, JT, 2020)
"Corticosterone treatment altered all parameters in behavioral tests, leading to a depressive- and anxious-like behavior."	1.51	Reversal effect of Riparin IV in depression and anxiety caused by corticosterone chronic administration in mice. ( Barbosa Filho, JM; Capibaribe, VCC; Chaves, RC; da Silva, DMA; de Carvalho, AMR; de Sousa, FCF; Gutierrez, SJC; Lopes, IS; Macêdo, DS; Mallmann, ASV; Oliveira, ICM; Oliveira, NF; Valentim, JT; Vasconcelos, SMM, 2019)
"A combined pharmacodynamic and pharmacokinetic approach was made to study the pharmacodynamic half-life (Pd1/2) of amitriptyline (AT)."	1.26	Decreased tyramine sensitivity after discontinuation of amitriptyline therapy. An index of pharmacodynamic half-life. ( Ghose, K, 1980)
"Nortriptyline is a preferential noradrenaline uptake inhibitor, while the dimethylated compound, chlorimipramine also has a profound influence on serotonin neurons."	1.26	Treatment of depression with tricyclic drugs--pharmacokinetic and pharmacodynamic aspects. ( Asberg, M, 1976)

Timeframe	Studies, this research(%)	All Research%
pre-1990	48 (76.19)	18.7374
1990's	3 (4.76)	18.2507
2000's	4 (6.35)	29.6817
2010's	6 (9.52)	24.3611
2020's	2 (3.17)	2.80

Authors	Studies
Chaves, RC	4
Mallmann, ASV	3
de Oliveira, NF	2
Capibaribe, VCC	4
da Silva, DMA	4
Lopes, IS	3
Valentim, JT	4
Barbosa, GR	1
de Carvalho, AMR	3
Fonteles, MMF	2
Gutierrez, SJC	4
Barbosa Filho, JM	3
de Sousa, FCF	4
Oliveira, ICM	3
Sartori, DP	1
Rodrigues, GC	2
Filho, AJMC	1
Riello, GB	1
Vasconcelos, SMM	2
Macedo, D	1
Filho, JMB	1
de Souza, AG	1
de Araújo, MA	1
Macêdo, DS	2
Oliveira, NF	1
Doron, R	1
Versano, Z	1
Burstein, O	1
Franko, M	1
Shamir, A	1
Toledano, R	1
Handelsman, A	1
Rehavi, M	1
Shulman, KI	1
Herrmann, N	1
Walker, SE	1
Vasconcelos, AS	1
Oliveira, IC	1
Vidal, LT	1
Gutierrez, SJ	1
Barbosa-Filho, JM	2
Vasconcelos, SM	2
de França Fonteles, MM	2
Gaspar, DM	1
de Sousa, FC	2
Melo, CT	1
de Carvalho, AM	1
Moura, BA	1
Teixeira, CP	1
Vasconcelos, LF	1
Feitosa, ML	1
de Oliveira, GV	1
Chavez Gutierrez, SJ	1
COOPER, AJ	1
KEDDIE, KM	1
BLACKWELL, B	1
MABBITT, LA	1
POLLITT, J	1
Marcason, W	1
Drozak, J	1
Kozłowski, M	1
Willeit, M	1
Sitte, HH	1
Thierry, N	1
Michalek, K	1
Praschak-Rieder, N	1
Zill, P	1
Winkler, D	1
Brannath, W	1
Fischer, MB	1
Bondy, B	1
Kasper, S	1
Singer, EA	1
Pare, CM	6
Kline, N	1
Hallstrom, C	1
Cooper, TB	1
Sandler, M	14
Ruthven, CR	2
Goodwin, BL	4
Reynolds, GP	2
Rao, VA	2
Coppen, A	8
Karoum, F	1
Chuang, LW	1
Eisler, T	1
Calne, DB	1
Liebowitz, MR	1
Quitkin, FM	1
Klein, DF	1
Wyatt, RJ	1
Wood, KM	1
Carter, SM	2
Reveley, MA	2
Dewhurst, J	1
Little, BC	1
Hayworth, J	1
Priest, RG	1
Ghose, K	7
Gillman, PK	1
Bridges, PK	3
Carter, SB	4
Glover, V	3
Rein, G	1
Gleiter, C	1
Volz, HP	2
Fahn, S	1
Chouinard, S	1
Gleiter, CH	1
Turcotte, JE	1
Debonnel, G	1
de Montigny, C	1
Hébert, C	1
Blier, P	1
Asberg, M	1
Cuthbert, MF	1
Turner, P	5
Isaac, P	1
Mitchell, B	1
Grahame-Smith, DG	1
Wood, K	1
Mulgirigama, LD	2
Wadsworth, J	2
Witts, DJ	2
Mann, J	1
Friedman, MJ	1
Sepping, P	2
Maany, I	1
Coppen, AJ	1
Szabadi, E	1
Besson, J	1
Bradshaw, CM	1
Jarman, J	1
Fernandez, M	1
Davies, PT	1
Thompson, C	2
Rose, FC	1
Checkley, SA	1
Corn, TH	1
Glass, IB	1
Franey, C	1
Arendt, J	1
Rafaelsen, OJ	1
Klaiber, EL	1
Kobayashi, Y	1
Broverman, DM	1
Hall, F	1
Youdim, MB	3
Raskin, A	1
Collins, GG	1
Bevan Jones, AB	1
Nicholson, WJ	1
Fann, WE	2
Davis, JM	2
Janowsky, DS	2
Kaufmann, JS	2
Cavanaugh, JH	1
Oates, JA	2
Markianos, E	1
Nyström, I	1
Dalton, K	1
Sjöqvist, F	1
Griffith, JD	1
Fischer, E	1
Heller, B	1
Miró, AH	1

Trial			Phase	Enrollment	Study Type	Start Date	Status
Effectiveness of the Norepinephrine and Serotonin Reuptake Inhibitor Levomilnacipran in Healthy Males[NCT03249311]			Phase 4	36 participants (Actual)	Interventional	2018-03-02	Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Article	Year
Current place of monoamine oxidase inhibitors in the treatment of depression. CNS drugs, 2013, Volume: 27, Issue:10 Topics: Antidepressive Agents; Clinical Trials as Topic; Depression; Drug Interactions; Food-Drug Interactio	2013
[Monoamine oxidase as a target for drug action]. Postepy higieny i medycyny doswiadczalnej (Online), 2006, Volume: 60 Topics: Alzheimer Disease; Animals; Antidepressive Agents; Antiparkinson Agents; Depression; Humans; Monoami	2006
Trace amine deficit in depressive illness: the phenylalanine connexion. Acta psychiatrica Scandinavica. Supplementum, 1980, Volume: 280 Topics: Adult; Biogenic Amines; Depression; Female; Humans; Male; Middle Aged; Octopamine; Phenethylamines;	1980
Monoamine oxidase inhibitors. A perspective on their use in the elderly. Drugs & aging, 1998, Volume: 13, Issue:5 Topics: Aged; Alzheimer Disease; Depression; Food-Drug Interactions; Humans; Monoamine Oxidase; Monoamine Ox	1998
Monoamine oxidases: the present status. International pharmacopsychiatry, 1974, Volume: 9, Issue:1 Topics: Animals; Antibodies; Biogenic Amines; Chemical Phenomena; Chemistry; Depression; Electrophoresis; Hi	1974

Article	Year
Enhanced serotonin transporter function during depression in seasonal affective disorder. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2008, Volume: 33, Issue:7 Topics: Adrenergic Uptake Inhibitors; Adult; Aged; Analysis of Variance; Depression; Dose-Response Relations	2008
[Moclobemide]. Deutsche medizinische Wochenschrift (1946), 1995, Aug-25, Volume: 120, Issue:34-35 Topics: Antidepressive Agents; Benzamides; Depression; Depressive Disorder; Humans; Isoenzymes; Moclobemide;	1995
Experience with tranylcypromine in early Parkinson's disease. Journal of neural transmission. Supplementum, 1998, Volume: 52 Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Depression; Erectile Dysfunction; Female; Foll	1998
Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2001, Volume: 24, Issue:5 Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Blood Pressure; Brain; Brain Chemistry; Clomipramin	2001
Autonomic actions and interactions of mianserin hydrochloride (Org. GB 94) and amitriptyline in patients with depressive illness. Psychopharmacology, 1976, Sep-17, Volume: 49, Issue:2 Topics: Amitriptyline; Autonomic Nervous System; Blood Pressure; Clinical Trials as Topic; Depression; Diben	1976
Clinical responses in depressed patients in relation to plasma levels of tricyclic antidepressants and tyramine pressor response. Postgraduate medical journal, 1977, Volume: 53 Suppl 4 Topics: Adjustment Disorders; Adult; Aged; Anthracenes; Clinical Trials as Topic; Clomipramine; Depression;	1977
Tyramine pressor responses and plasma levels during tricyclic antidepressant therapy. Postgraduate medical journal, 1977, Volume: 53 Suppl 4 Topics: Anthracenes; Blood Pressure; Clinical Trials as Topic; Clomipramine; Depression; Dibenzazepines; Dou	1977
Clinical and pharmacological effects of treatment with a new antidepressant. Arzneimittel-Forschung, 1976, Volume: 26, Issue:6 Topics: Adjustment Disorders; Amitriptyline; Blood Pressure; Clinical Trials as Topic; Depression; Dibenzaze	1976
Plasma monoamine oxidase activity in regularly menstruating women and in amenorrheic women receiving cyclic treatment with estrogens and a progestin. The Journal of clinical endocrinology and metabolism, 1971, Volume: 33, Issue:4 Topics: Adolescent; Adult; Aged; Amenorrhea; Amines; Analysis of Variance; Brain; Catecholamines; Clinical T	1971
Adverse reactions to phenelzine: results of a nine-hospital depression study. The Journal of clinical pharmacology and new drugs, 1972, Volume: 12, Issue:1 Topics: Adolescent; Adult; Clinical Trials as Topic; Depression; Diet; Female; Headache; Humans; Hypertensio	1972
Effect of antidepressant and antimanic drugs on amine uptake in man. The Journal of nervous and mental disease, 1974, Volume: 158, Issue:5 Topics: Antidepressive Agents; Biological Transport; Bipolar Disorder; Blood Platelets; Blood Pressure; Brai	1974
A pharmacokinetic approach to the treatment of depression. International pharmacopsychiatry, 1971, Volume: 6, Issue:3 Topics: Barbiturates; Biotransformation; Blood Pressure; Chromatography, Gas; Clinical Trials as Topic; Deal	1971

tyramine and Depression

Research Excerpts

Research

Studies (63)

Authors

Clinical Trials (1)

Trial Overview

Reviews

Trials

Other Studies

Article	Year
The neuroprotective effect of Riparin IV on oxidative stress and neuroinflammation related to chronic stress-induced cognitive impairment. Hormones and behavior, 2020, Volume: 122 Topics: Animals; Antioxidants; Behavior, Animal; Brain; Chronic Disease; Cognitive Dysfunction; Corticostero	2020
Is Riparin III a promising drug in the treatment for depression? European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2021, Jul-01, Volume: 162 Topics: Animals; Behavior, Animal; Benzamides; Corticosterone; Depression; Disease Models, Animal; Female; M	2021
Riparin II ameliorates corticosterone-induced depressive-like behavior in mice: Role of antioxidant and neurotrophic mechanisms. Neurochemistry international, 2018, Volume: 120 Topics: Animals; Antidepressive Agents; Antioxidants; Behavior, Animal; Benzamides; Brain-Derived Neurotroph	2018
Reversal effect of Riparin IV in depression and anxiety caused by corticosterone chronic administration in mice. Pharmacology, biochemistry, and behavior, 2019, Volume: 180 Topics: Amides; Anhedonia; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Behavior, Animal; B	2019
Cerebral MAO Activity Is Not Altered by a Novel Herbal Antidepressant Treatment. Journal of molecular neuroscience : MN, 2019, Volume: 69, Issue:3 Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Citalopram; Corpus Striatum; Crataegus; Depress	2019
Subchronic administration of riparin III induces antidepressive-like effects and increases BDNF levels in the mouse hippocampus. Fundamental & clinical pharmacology, 2015, Volume: 29, Issue:4 Topics: Anhedonia; Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Benzamides; Brain-Derived Neur	2015
Evidence for the involvement of the serotonergic, noradrenergic, and dopaminergic systems in the antidepressant-like action of riparin III obtained from Aniba riparia (Nees) Mez (Lauraceae) in mice. Fundamental & clinical pharmacology, 2013, Volume: 27, Issue:1 Topics: Administration, Oral; Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-2 Receptor Agonists; An	2013
HYPOTENSIVE COLLAPSE AND HYPOGLYCAEMIA AFTER MEBANAZINE--A MONOAMINE-OXIDASE INHIBITOR. Lancet (London, England), 1964, May-23, Volume: 1, Issue:7343 Topics: Biomedical Research; Cheese; Depression; Ephedrine; Hydrazines; Hypoglycemia; Hypoglycemic Agents; H	1964
TYRAMINE IN CHEESE RELATED TO HYPERTENSIVE CRISES AFTER MONOAMINE-OXIDASE INHIBITION. Lancet (London, England), 1965, May-01, Volume: 1, Issue:7392 Topics: Cheese; Chromatography; Colorimetry; Depression; Depressive Disorder; Drug Therapy; Electrophoresis;	1965
THE DIAGNOSIS AND MANAGEMENT OF DEPRESSION. The Practitioner, 1965, Volume: 194 Topics: Amitriptyline; Analgesics; Analgesics, Non-Narcotic; Antipyretics; Classification; Depression; Depre	1965
What is the bottom line for dietary guidelines when taking monoamine oxidase inhibitors? Journal of the American Dietetic Association, 2005, Volume: 105, Issue:1 Topics: Antidepressive Agents; Blood Pressure; Cheese; Depression; Food-Drug Interactions; Humans; Monoamine	2005
Will amitriptyline prevent the "cheese" reaction of monoamine-oxidase inhibitors? Lancet (London, England), 1982, Jul-24, Volume: 2, Issue:8291 Topics: Adult; Amitriptyline; Blood Pressure; Cheese; Depression; Drug Synergism; Female; Humans; Hypertensi	1982
Metabolism of (-) deprenyl to amphetamine and methamphetamine may be responsible for deprenyl's therapeutic benefit: a biochemical assessment. Neurology, 1982, Volume: 32, Issue:5 Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Amphetamines; Biogenic Amines; Carbidopa; Depression; Drug Co	1982
Peripheral serotonergic and adrenergic responses in depression. Acta psychiatrica Scandinavica. Supplementum, 1980, Volume: 280 Topics: Affective Symptoms; Amitriptyline; Blood Platelets; Blood Pressure; Depression; Female; Humans; Male	1980
Decreased urinary output of conjugated tyramine is associated with lifetime vulnerability to depressive illness. Psychiatry research, 1980, Volume: 3, Issue:1 Topics: Chronic Disease; Depression; Female; Humans; Pregnancy; Psychiatric Status Rating Scales; Socioecono	1980
Monoamine oxidase inhibitors for depression. The Medical letter on drugs and therapeutics, 1980, Jul-11, Volume: 22, Issue:14 Topics: Depression; Drug Interactions; Food; Food Analysis; Humans; Monoamine Oxidase Inhibitors; Tyramine	1980
Decreased tyramine sensitivity after discontinuation of amitriptyline therapy. An index of pharmacodynamic half-life. European journal of clinical pharmacology, 1980, Volume: 18, Issue:2 Topics: Adult; Amitriptyline; Blood Pressure; Depression; Drug Interactions; Female; Half-Life; Humans; Male	1980
Decreased conjugated tyramine output in depression: the effect of oral L-cysteine. British journal of clinical pharmacology, 1980, Volume: 10, Issue:3 Topics: Cysteine; Depression; Female; Humans; Male; Phenylacetates; Tyramine	1980
Further light on the tyramine test in depression. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1980, Volume: 7, Issue:3 Topics: Affective Disorders, Psychotic; Depression; Diagnosis, Differential; Female; Humans; Pregnancy; Puer	1980
Treatment of depression with tricyclic drugs--pharmacokinetic and pharmacodynamic aspects. Pharmakopsychiatrie, Neuro-Psychopharmakologie, 1976, Volume: 9, Issue:1 Topics: Antidepressive Agents, Tricyclic; Clomipramine; Depression; Homovanillic Acid; Humans; Hydroxyindole	1976
Is there an increase in monoamine-oxidase activity in depressive illness? Lancet (London, England), 1975, May-10, Volume: 1, Issue:7915 Topics: Administration, Oral; Adult; Aged; Circadian Rhythm; Depression; Humans; Iproniazid; Isoproterenol;	1975
Intravenous tyramine pressor response in depression. Lancet (London, England), 1975, Jun-14, Volume: 1, Issue:7920 Topics: Adult; Blood Pressure; Depression; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Inj	1975
Letter: Tyramine pressor response in depression. Lancet (London, England), 1975, Sep-13, Volume: 2, Issue:7933 Topics: Blood Pressure; Depression; Humans; Tyramine	1975
Monoamine-oxidase inhibitors and caviar. Lancet (London, England), 1977, Oct-15, Volume: 2, Issue:8042 Topics: Aged; Animals; Depression; Drug Combinations; Drug Synergism; Eggs; Female; Fishes; Humans; Hyperten	1977
The biochemistry of depression. Lancet (London, England), 1978, Feb-25, Volume: 1, Issue:8061 Topics: Biotransformation; Depression; Histocytochemistry; Humans; Tyramine	1978
Peripheral alpha-adrenoreceptor and central dopamine receptor activity in depressive patients. Psychopharmacology, 1978, Oct-31, Volume: 59, Issue:2 Topics: Adult; Amitriptyline; Blood Pressure; Bromocriptine; Depression; Female; Humans; Male; Norepinephrin	1978
Adrenergic and serotonergic mechanisms in depression and their response to amitriptyline. Ciba Foundation symposium, 1979, Issue:74 Topics: Amitriptyline; Blood Platelets; Blood Pressure; Depression; Female; Humans; Male; Norepinephrine; Ph	1979
Deficient production of tyramine and octopamine in cases of depression. Nature, 1979, Mar-22, Volume: 278, Issue:5702 Topics: Aged; Depression; Female; Homovanillic Acid; Humans; Hydroxy Acids; Male; Mandelic Acids; Middle Age	1979
Noradrenaline, depressive illness, and the action of amitriptyline. Psychopharmacology, 1977, Aug-31, Volume: 54, Issue:1 Topics: Adult; Aged; Amitriptyline; Blood Pressure; Depression; Female; Humans; Male; Middle Aged; Norepinep	1977
Altered platelet monoamine oxidase activity in affective disorders. Psychological medicine, 1979, Volume: 9, Issue:4 Topics: Adjustment Disorders; Adult; Aged; Benzylamine Oxidase; Bipolar Disorder; Blood Platelets; Depressio	1979
Does receptor supersensitivity accompany depressive illness? The American journal of psychiatry, 1978, Volume: 135, Issue:1 Topics: Bipolar Disorder; Blood Pressure; Depression; Dose-Response Relationship, Drug; Humans; Male; Norepi	1978
Decreased urinary output of tyramine and its metabolites in depression. The British journal of psychiatry : the journal of mental science, 1978, Volume: 132 Topics: Administration, Oral; Adult; Aged; Depression; Diazepam; Female; Humans; Male; Middle Aged; Nitrazep	1978
Decreased conjugated tyramine outputs in depression: gastrointestinal factors. British journal of clinical pharmacology, 1978, Volume: 5, Issue:3 Topics: Depression; Diphenoxylate; Gastrointestinal Motility; Humans; Metoclopramide; Sulfates; Time Factors	1978
Adrenergic receptor sensitivity and depressive illness. The American journal of psychiatry, 1978, Volume: 135, Issue:8 Topics: Depression; Humans; Norepinephrine; Phenylephrine; Receptors, Adrenergic; Tyramine	1978
Pupil responsiveness to tyramine in depressed patients treated with amitriptyline. British journal of clinical pharmacology, 1975, Volume: 2, Issue:4 Topics: Adult; Amitriptyline; Depression; Drug Interactions; Female; Humans; Middle Aged; Pupil; Tyramine	1975
Tyramine sulfoconjugation in relation to depression in migraine. A pilot study. The Clinical journal of pain, 1989, Volume: 5, Issue:1 Topics: Depression; Diet; Humans; Migraine Disorders; Sulfates; Tyramine	1989
Neuroendocrine and other studies of the mechanism of antidepressant action of desipramine. Ciba Foundation symposium, 1986, Volume: 123 Topics: Animals; Blood Pressure; Clonidine; Depression; Desipramine; Growth Hormone; Humans; Melatonin; Phen	1986
Cheese effects and new reversible MAO A inhibitors: summary. Journal of neural transmission. Supplementum, 1988, Volume: 26 Topics: Cheese; Depression; Humans; Monoamine Oxidase Inhibitors; Tyramine	1988
Clinical chemistry of monoamine oxidase. Cell biochemistry and function, 1986, Volume: 4, Issue:2 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Blood Platelets; Brain; Clorgyline; Depressio	1986
Proceedings: Multiple forms of MAO: some in vivo correlations. Psychopharmacology bulletin, 1974, Volume: 10, Issue:3 Topics: Chemical Phenomena; Chemistry; Depression; Dopamine; Humans; Monoamine Oxidase; Monoamine Oxidase In	1974
Human brain monoamine oxidase: multiple forms and selective inhibitors. Nature, 1972, Mar-31, Volume: 236, Issue:5344 Topics: Aged; Amines; Basal Ganglia; Brain; Carbon Isotopes; Cerebellum; Cerebral Cortex; Depression; Dopami	1972
[Study on dopamine beta hydroxylase in serum]. Arzneimittel-Forschung, 1974, Volume: 24, Issue:7 Topics: Adult; Age Factors; Alcoholism; Carbon Radioisotopes; Chromatography; Chromatography, Gas; Depressio	1974
Migraine--a personal view. The Practitioner, 1972, Volume: 209, Issue:254 Topics: Contraceptives, Oral; Depression; Female; Food Hypersensitivity; Humans; Hypoglycemia; Male; Menstru	1972
New look at monoamine oxidase inhibitors. The new biochemical background. Proceedings of the Royal Society of Medicine, 1973, Volume: 66, Issue:9 Topics: Brain; Depression; Dopamine; Humans; Hydrogen-Ion Concentration; Migraine Disorders; Mitochondria; M	1973
Effect of iprindole on amine uptake in man. Archives of general psychiatry, 1972, Volume: 26, Issue:2 Topics: Amines; Antidepressive Agents; Biogenic Amines; Blood Platelets; Blood Pressure; Brain Chemistry; Cy	1972
Beta-phenylethylamine in human urine. Arzneimittel-Forschung, 1968, Volume: 18, Issue:11 Topics: Alcoholism; Antisocial Personality Disorder; Chronic Disease; Depression; Humans; Phenethylamines; P	1968